Abstract Background and Objectives: Hyperbaric oxygen is a recognised treatment for a range of medical conditions, including treatment of diabetic foot disease. A number of studies have reported an impact of hyperbaric oxygen treatment on glycaemic control in patients...
Diabetes
Hyperbaric Oxygen Therapy (HBOT) Research for Diabetes.
Hyperbaric Oxygen Therapy for Diabetes
Diabetes affects more than 12 million people annually, and the experienced team at Skaggs Chiropractic in Joplin is always seeking the most effective methods to help our patients with diabetes. Hyperbaric oxygen therapy (HBOT) does just that for patients living with...
Hyperbaric Oxygen Therapy and Vascular Complications in Diabetes Mellitus
Abstract Vascular complications in patients with diabetes mellitus (DM) are common. Since impaired oxygen balance in plasma plays an important role in the pathogenesis of chronic DM-associated complications, the administration of hyperbaric oxygen therapy (HBOT) has...
Role of Hyperbaric Oxygen Therapy on Microvascular Diabetic Complications and Metabolic Profile among Patients with Type 2 Diabetes Mellitus
No abstract available Al-Rawahi A. Role of Hyperbaric Oxygen Therapy on Microvascular Diabetic Complications and Metabolic Profile among Patients with Type 2 Diabetes Mellitus. Oman Med J. 2020 Jun 1;35(3):e129. doi: 10.5001/omj.2020.47. PMID: 32489679; PMCID:...
A systematic review and meta-analysis of hyperbaric oxygen therapy for diabetic foot ulcers with arterial insufficiency
Abstract: BackgroundDiabetic foot ulcers (DFUs) are frequently associated with peripheral arterial occlusive disease (PAOD) and may ultimately lead to amputations of the lower extremity. Adjuvant hyperbaric oxygen treatment (HBOT) might foster better wound healing and...
The clinical use of hyperbaric oxygen in the treatment of Danish patients with diabetic foot ulcers.
Patients with diabetic foot ulcers (DFU) suffer from diabetes-related complications and comor-bidities. Hyperbaric oxygen therapy (HBOT) is a treatment modality with limited capacity used in the treatment of DFUs. It is important to ensure that HBOT is offered to patients who are suitable for this treatment regarding effect, compliance and life expectancy. The objective of the present study was to describe the population of patients with DFU who were referred to HBOT in Denmark in the 1999-2016 period. All patients with DFU who were treated at the HBOT chamber in Copenhagen during the study period were considered. Patients with an invalid social security number or an incorrect diagnosis were excluded. Data on comor-bidities, amputation and death were extracted from the Danish National patient Registry and the Danish Civil Registration System.
Vitamin C for Type 2 Diabetes Mellitus and Hypertension
Abstract It is suggested that supplementation of vitamin C reduces hyperglycemia and lowers blood pressure in hypertensives by enhacing the formation of prostaglandin E1 (PGE1), PGI2 (prostacyclin), endothelial nitric oxide (eNO), and restore essential fatty acid...
Effects of far infrared therapy on neuropathy in type 2 diabetes mellitus: a randomized controlled trial
Diabetes is associated with many severe complications, such as heart disease and nerve damage. Diabetics have elevated blood glucose levels that result in peripheral neuropathy. As a result, diabetics always feel painful about their lower limbs and may need to have...
Malnutrition screening in outpatients receiving hyperbaric oxygen therapy: an opportunity for improvement?
Outpatients who receive hyperbaric oxygen treatment (HBOT) may represent a group at significant risk of malnutrition owing to the underlying conditions that are often treated with HBOT (e.g., non-healing diabetic wounds and radiation-induced skin injury). In this issue, See and colleagues provide new, preliminary evidence of the prevalence of malnutrition in a small group of HBOT outpatients treated in an Australian hospital, reporting that approximately one-third of patients receiving HBOT were at risk of malnutrition. To our knowledge, routine malnutrition screening is not available in HBOT centres providing outpatient treatment, which may be a key gap in the nutrition care of these patients. Malnutrition screening was developed to identify those at risk of malnutrition across the healthcare continuum.